804 First-in-Human Xenotransplantation US-FDA-Clinical Trials - Complete Wound Closure of Mixed-Depth Burns via Porcine Skin Xenotransplant

Bounthavy F Homsombath,Paul Holzer,Kaitlyn M Rogers,Joshua C Doloff,Steve Gullans,Robert A Kaiser,Harold Swartz,Curtis L Cetrulo, Jr.,Linda Scobie,Rod Monroy,Jeremy Goverman

DOI: https://doi.org/10.1093/jbcr/irae036.344

2024-04-17

Journal of Burn Care & Research

Abstract:Abstract Introduction Currently there is no treatment than can provide complete and durable wound closure of mixed-depth burn injuries, other than intact human skin, which has several drawbacks. An alternative would be a significant advancement in burn care and a meaningful benefit to patient care. We report here the results of the first-in-human, US-FDA xenotransplantation clinical trial: the use of skin xenotransplants containing live (i.e., non-terminally sterilized, non-xenograft) epidermal and dermal tissues derived from genetically altered, pathogen-free porcine donors to provide complete and durable wound closure of mixed-depth burn wounds. Methods 22 patients with mixed-depth burn wounds were enrolled in Phase 1/2/2b US-FDA clinical trials to evaluate the safety and efficacy of skin xenotransplants to provide complete and durable wound closure in a side-by-side comparison with human allograft. Results To date, there have been zero adverse events including any xeno-related pathologies. In all patients, complete and durable wound closure was demonstrated at all xeno-treatment sites. In 3 cases, mixed-depth burns treated with the skin xenotransplant did not require autografting. Conclusions These clinical data demonstrate the ability of a live, genetically altered skin xenotransplant to facilitate complete and durable wound closure in mixed-depth burn wounds, and that the use of skin xenotransplants may potentially reduce the need for autografting in the treatment of mixed-depth burns. These claims will be evaluated in a US-FDA Phase 3 clinical trial. Applicability of Research to Practice First-in-Human Xenotransplant; Complete, Durable Wound Closure of Mixed, Depth, Full-Thickness Burn Wounds.

dermatology,surgery,critical care medicine

What problem does this paper attempt to address?

### Problems Attempted to Solve by the Papers

#### First Paper
**Title**: S262 American Burn Association 56th Annual Meeting Abstract Citation ID: irae036.344
**Background**: Currently, there are no other treatments besides full human skin grafts that can provide complete and durable closure of mixed-depth burn wounds. Human skin grafts have multiple drawbacks, so finding alternative methods would significantly improve burn care and have a major impact on patient care.

**Problem**: This paper attempts to address the issue of mixed-depth burn wounds not achieving complete and durable closure with existing methods. Specifically, the researchers conducted a first-in-human xenotransplantation clinical trial using live epidermal and dermal tissues from genetically modified, pathogen-free pig skin to evaluate its safety and efficacy in providing complete and durable closure of mixed-depth burn wounds.

#### Second Paper
**Title**: 805 A Simple Technique for Creating Partial Thickness Wounds and Harvesting Split-Thickness Skin Grafts in a Rat Model
**Background**: Developing reliable methods to generate consistently sized partial thickness (PT) wounds in rats is crucial for testing and developing new wound healing strategies. Current methods make it difficult to harvest split-thickness skin grafts (STSG) in rats because rat skin is loose and their body size is small. Existing methods can be time-consuming, require additional equipment, or cannot be performed by a single person.

**Problem**: This paper attempts to solve the difficulty of creating partial thickness wounds and harvesting split-thickness skin grafts in rats. The researchers proposed a new single-person solution using a circular dermatome and validated the reliability of this technique in creating consistently thick STSG and PT wounds.